Becker's Healthcare November 18, 2024
The Drug Enforcement Administration will extend rules allowing providers to prescribe controlled substances via telehealth through the end of 2025.
In a news release published Nov. 15, the agency says it is “continuing to consider” feedback it received on telehealth prescribing rules and is working toward a final rule.
During the COVID-19 pandemic, the DEA implemented several telehealth flexibilities, including allowing prescribing of controlled substances. Before the pandemic, patients were required to have at least one in-person visit with a provider before they could receive controlled substances via telehealth.
Here are three things for behavioral health leaders to note:
- Proponents of the policy argue telehealth increases access to medication-assisted treatment for opioid use disorder treatment...